Reducing stimulant use and HIV risk among young gay and bisexual men
RP7 Impact
This study is testing a program called Project IMPACT to help young gay and bisexual men reduce their use of stimulant drugs and lower their risk of HIV by encouraging them to engage in fun activities and providing support for staying healthy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Florida State University NIH-funded |
| Lab location | 1 site (Tallahassee, United States) |
| Project ID | NIH-10993612 on NIH RePORTER |
What this research studies
This research investigates the effectiveness of a behavioral intervention called Project IMPACT, aimed at reducing stimulant drug use and associated HIV risks among young gay, bisexual, and other men who have sex with men (YGBMSM). The intervention combines HIV risk reduction counseling with behavioral activation, a cognitive behavioral approach that encourages individuals to engage in enjoyable activities that do not involve drug use. By addressing both stimulant use and mental health, the study seeks to improve overall well-being and reduce risky sexual behaviors. Participants will receive support for HIV prevention strategies, including PrEP and antiretroviral therapy.
Who could benefit from this research
Good fit: Ideal candidates for this research are young gay, bisexual, and other men who have sex with men and are currently using stimulant drugs.
Not a fit: Patients who do not use stimulants or who are not part of the target demographic of young gay and bisexual men may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly lower HIV transmission rates and improve the mental health of young gay and bisexual men who use stimulants.
How similar studies have performed: Previous research has shown promise in using behavioral interventions to address substance use and HIV risk, indicating that this approach may be effective.
Where this research is happening
Tallahassee, United States
- Florida State University — Tallahassee, United States (Active)
Researchers
- Principal investigator: Hightow-Weidman, Lisa B — Florida State University
- Study coordinator: Hightow-Weidman, Lisa B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.